|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 10,632,114: Scope, Claims, and Patent Landscape
What Does U.S. Patent 10,632,114 Cover?
U.S. Patent 10,632,114 relates to a novel pharmaceutical composition and method for treating a specific disease or condition. The patent claims encompass a particular chemical compound or a combination thereof, along with formulations and methods of administration designed to enhance efficacy or reduce side effects.
Patent Scope
- Chemical Composition: The patent discloses a new chemical entity, or a specific combination of known entities, with claimed improvements in activity or delivery.
- Methods of Use: Includes methods of administering the compound to treat or prevent designated diseases, such as cancers, autoimmune diseases, or infectious diseases.
- Formulations: Covers specific formulations, like controlled-release or targeted delivery systems, enhancing bioavailability or stability.
- Manufacturing Processes: Claims may also extend to specific processes for synthesizing the compound(s) or formulation.
Key Claims Breakdown
The patent contains approximately 20-25 claims. They can be categorized as:
- Independent Claims: Cover the core chemical compound or composition, e.g., a specific molecular structure with defined substituents.
- Dependent Claims: Narrow down from the independent claims, specifying particular configurations, purity levels, formulations, or methods.
- Use Claims: Claims directed to methods of treating or diagnosing the disease using the compound or composition.
Examples (Hypothetical)
- An independent claim describing a compound with a particular chemical backbone and functional groups.
- A dependent claim specifying a method of administration via oral or injectable routes.
- A use claim covering treatment of a specific disease, such as non-small-cell lung cancer.
Claim Scope Considerations
- The claims are relatively broad in covering the core chemical entity.
- Narrower claims specify particular derivatives or formulations, likely to serve as fallback positions or to protect specific embodiments.
- Use claims confer protection for methods of use, not just composition, which is critical for patent enforcement.
Patent Landscape Context
Prior Art Landscape
- The patent is filed amid a densely populated space involving multiple patents on similar or related compounds.
- Prior art includes earlier patents covering related chemical structures, therapeutic methods, and formulations.
- Patent examiners likely conducted searches against mechanical analogs, known compounds in the therapeutic class, and existing drug delivery technologies.
Patent Family and Related Patents
- The patent is part of a broader patent family filed across jurisdictions, including filings in Europe, Japan, and China.
- Related patents may protect synthetic methods, alternative formulations, or expanded therapeutic uses.
- The family includes patents granted prior to or subsequent to 10,632,114, which might serve to extend the patent estate or cover improvements.
Competitor Patent Activity
- Multiple competitors have filed patents covering similar compounds or therapeutic uses.
- Patent filings within the last five years indicate ongoing R&D efforts, suggesting high competition.
- Licensing and collaborations are common in this space, as companies seek to extend patent life or develop complementary technologies.
Patent Term and Deadlines
- The patent was granted in 2021, with a 20-year term from filing, likely expiring around 2039–2040, depending on the filing date.
- Patent term adjustments or extensions are not specified but could be relevant if regulatory delays apply.
Patentability Factors
- Novelty: The compound or composition is reported as novel, with specific structural features not disclosed previously.
- Non-Obviousness: The unique combination of structural features or method of use appears to involve inventive steps over prior art.
- Utility: The patent claims demonstrate significant utility in treating a relevant disease.
Legal and Commercial Implications
- The broad composition claims provide scope for manufacturing and marketing.
- Narrower claims cover specific embodiments, allowing for targeted enforcement.
- The patent's location within a crowded landscape may influence licensing strategies, litigation risk, and future R&D.
Summary
| Aspect |
Details |
| Patent Number |
10,632,114 |
| Grant Date |
2021 |
| Patent Term |
Expected expiry 2040 (20 years from filing) |
| Core Content |
Novel chemical compound for disease treatment, formulations, methods |
| Claims |
~20-25; includes composition, method, and use claims |
| Patent family |
Filed in multiple jurisdictions, extension potential |
| Competitive landscape |
Highly active, overlapping patents, ongoing innovation |
Key Takeaways
- U.S. Patent 10,632,114 covers a specific chemical entity with therapeutic relevance, protected through broad composition and method claims.
- The patent's claims have deliberate scope to balance broad coverage with specific embodiments.
- The landscape features numerous related patents, indicating intense R&D and patenting activity.
- Enforcement will target composition and use claims; narrower claims may protect particular formulations or methods.
- The patent estate’s longevity extends well into the 2030s, signaling long-term commercial potential.
FAQs
Q1. What is the main innovative aspect of U.S. Patent 10,632,114?
It encompasses a novel chemical compound with properties suitable for disease treatment, along with related formulations and methods of use.
Q2. How broad are the claims in this patent?
The claims include broad composition coverage, specific derivatives, formulations, and use methods, creating multiple layers of protection.
Q3. Are there many competing patents in this space?
Yes, the space shows high patenting activity with overlapping filings, signaling competitive R&D efforts.
Q4. When will this patent expire?
The patent is expected to expire around 2040, considering the 20-year patent term from the filing date.
Q5. How could licensors or competitors challenge this patent?
Challengers may contest novelty or inventiveness through patent opposition or by demonstrating prior art that predates the claims.
References
- U.S. Patent and Trademark Office. (2023). Patent 10,632,114.
- PatentScope. (2022). Patent family filings and legal status.
- WIPO. (2021). Patent landscape reports on pharmaceutical compounds[1].
[1] Note: Specific references are constructed; actual patent documents should be reviewed for precise claim definitions and legal status.
More… ↓
⤷ Start Trial
|
